PetCaseFinder

Peer-reviewed veterinary case report

Nonsecretory multiple myeloma causing bone lesions in a Chihuahua

By Marks, S L et al.·Published in Journal of veterinary internal medicine·1995·Department of Molecular Biosciences, United States·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Nonsecretory multiple myeloma in a dog: immunohistologic and ultrastructural observations.

Species:
dog
Canine melanomaBrain & nervesDogs

Plain-English summary

A 12-year-old female spayed Chihuahua was diagnosed with nonsecretory multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. The dog showed signs of multiple bone lesions and neurological issues, but treatment with prednisone, a steroid, did not help her condition. Unfortunately, she was euthanized two weeks after her diagnosis due to worsening symptoms. The tests showed that the tumor cells did not react to common markers for certain immune cells, indicating a unique form of the disease.

People also search for: Chihuahua cancer symptoms · dog multiple myeloma treatment · why is my dog losing weight and acting weak

Abstract

A 12-year-old, female spayed Chihuahua was diagnosed with nonsecretory multiple myeloma on the basis of multiple osteolytic lesions, histological evidence of plasma cell infiltrate on a bone biopsy, and absence of a monoclonal protein on serum and urine electrophoresis. A 6-week course of prednisone therapy resulted in no clinical improvement and the dog was euthanized 2 weeks after presentation because of progressive neurological impairment. Bone marrow specimens were processed and stained for ultrastructural and immunohistologic evaluation. Staining with antisera to immunoglobulin (Ig) G, IgM, and IgA was negative. Tumor cells in both the pelvic and rib masses displayed prominent reactivity with an antibody specific for a canine beta 1 integrin similar to VLA-4; however, the tumor cells failed to stain with antibodies known to react predominantly with antigens on B-lymphocytes (major histocompatibility complex class II, CD45RA, and CD21) or T-lymphocytes (Thy-1). The tumor cells also failed to stain with an antibody specific for the beta-subunit (CD18) of the leukocyte integrins (D11/CD18). Ultrastructural studies performed on bone marrow specimens revealed a pleomorphic population of plasma cells with moderate amounts of rough endoplasmic reticulum, erythrophagocytosis, and lack of crystalline inclusions.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/7891363/